Background: Picosecond (PS) lasers were approved by the US FDA in 2012 after being shown to remove tattoos with more success and fewer treatments compared with traditional methods. PS lasers were shown to be versatile, indicated for the treatment of lentigines, café-au-lait macules (CALMs), and acne scars and skin rejuvenation.
Objective: We report our experience treating our patients for different indications using a PS laser.
Methods: We performed a retrospective chart and photographic review of all patients seen between 2016 and 2018 that were treated in our centers with a PS laser for nontattoo indications. Clinical outcomes were evaluated using side-by-side comparisons of the clinical photographs by two blinded, independent physicians using a visual analog scale consisting of six levels of treatment response.
Results: A total of 233 patients were studied. Most sought treatment for solar lentigo (27%) and skin rejuvenation (14%). Epidermal nevi exhibited the greatest improvement with treatment, while acne scarring demonstrated the least. Only 24% of patients experienced noteworthy, transient adverse effects.
Conclusion: Picosecond lasers were efficacious and safe for a variety of indications. They were effective in treating epidermal nevi and pigmented lesions, such as Lentigines and CALMs.
Keywords: aesthetic improvement; epidermal nevus; laser treatment; picosecond laser; solar lentigines.
© 2019 Wiley Periodicals, Inc.
Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.Lasers Surg Med. 2016 Feb;48(2):181-7. doi: 10.1002/lsm.22454. Lasers Surg Med. 2016. PMID: 26922302
Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.Lasers Surg Med. 2019 Jan;51(1):14-22. doi: 10.1002/lsm.23028. Epub 2018 Oct 25. Lasers Surg Med. 2019. PMID: 30357871
Picosecond 532-nm neodymium-doped yttrium aluminium garnet laser-a novel and promising modality for the treatment of café-au-lait macules.Lasers Med Sci. 2018 May;33(4):693-697. doi: 10.1007/s10103-017-2373-9. Epub 2017 Nov 2. Lasers Med Sci. 2018. PMID: 29098459
Laser treatment of pigmented lesions in children.Semin Cutan Med Surg. 1999 Sep;18(3):233-43. doi: 10.1016/s1085-5629(99)80021-2. Semin Cutan Med Surg. 1999. PMID: 10468043 Review.
Laser treatment of dark skin: an updated review.Am J Clin Dermatol. 2010 Dec 1;11(6):389-97. doi: 10.2165/11538940-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20866114 Review.
- Graber E, Iyengar V, Rohrer T, Arndt K. Laser treatment of tattoos and pigmented lesions. In: Surgery of the Skin: Procedural Dermatology, 2nd edn. China: Mosby; 2010:537-548.
- Liu T, Wang J, Petrov GI, Yakovlev VV, Zhang HF. Photoacoustic generation by multiple picosecond pulse excitation. Med Phys. 2010;37(4):1518-1521.
- Forbat E, Al-Niaimi F. The use of picosecond lasers beyond tattoos. J Cosmet Laser Ther. 2016;18(6):345-347.
- Artzi O, Mehrabi JN, Koren A, Niv R, Lapidoth M, Levi A. Picosecond 532-nm neodymium-doped yttrium aluminium garnet laser-a novel and promising modality for the treatment of café-au-lait macules. Lasers Med Sci. 2018;33(4):693-697.
- Chesnut C, Diehl J, Lask G. Treatment of nevus of Ota with a picosecond 755-nm alexandrite laser. Dermatol Surg. 2015;41(4):508-510.